{
  "id": 18367397,
  "title": "Choosing the Initial Treatment Approach in HER2-Positive Breast Cancer",
  "url": "https://urgent.news/2026/11/05/choosing-the-initial-treatment-approach-in-her2-positive-breast-cancer",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-05T19:48:07.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/beyond-diagnosis/her2-ebc/123733"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- In \"Beyond Diagnosis: Early HER2-Positive Breast Cancer,\" Cleveland Clinic breast oncologist Megan Kruse, MD, and host John Mangels discuss how clinicians can navigate increasingly complex treatment decisions while helping patients...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}